GENEVA, March 30 -- PFIZER INC. (66 Hudson Boulevard EastNew York, New York 10001-2192) filed a patent application (PCT/IB2025/059360) for "SIRP ALPHA FUSION PROTEIN FORMULATION" on Sep 18, 2025. With publication no. WO/2026/062544, the details related to the patent application was published on Mar 26, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): GUO, Jianxin (210 Cheval Square Dr.Chesterfield, Missouri 63005), RODRIGUEZ NASSIF, Aslin Marie (c/o Pfizer Inc.700 Chesterfield Parkway W.Chesterfield, Missouri 63017)
Abstract: The present invention relates to the field of pharmaceutical formu...